Stocks Overview

LAST PRICE
27.3100
TODAY'S CHANGE (%)
0.0000 (0.0000%)

Bid / Lots
---/ ---
Ask / Lots
---/ ---
Open / Previous Close
--- / 27.3100
Day Range
---
52 Week Range
Low 24.1600
High 42.4550
Volume
---
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Friday's close: 27.13
Time	Volume	GLPG
09:32 ET	3889	27.57
09:33 ET	4400	27.65
09:37 ET	2396	27.67
09:39 ET	2265	27.745
09:42 ET	200	27.78
09:44 ET	2609	27.75
09:46 ET	7292	27.54
09:48 ET	1585	27.57
09:50 ET	3483	27.6
09:51 ET	700	27.58
09:53 ET	987	27.53
10:04 ET	665	27.5
10:06 ET	1320	27.5
10:08 ET	300	27.5
10:13 ET	1200	27.46
10:15 ET	3094	27.46
10:18 ET	100	27.465
10:20 ET	600	27.51
10:24 ET	100	27.54
10:27 ET	1300	27.455
10:29 ET	200	27.41
10:31 ET	300	27.47
10:33 ET	167	27.49
10:36 ET	545	27.52
10:40 ET	300	27.49
10:42 ET	300	27.45
10:44 ET	100	27.42
10:47 ET	600	27.43
10:49 ET	200	27.5
10:51 ET	300	27.48
10:54 ET	100	27.45
10:56 ET	300	27.46
10:58 ET	500	27.5
11:00 ET	100	27.45
11:02 ET	300	27.42
11:03 ET	800	27.44
11:07 ET	300	27.475
11:09 ET	100	27.445
11:12 ET	350	27.39
11:16 ET	484	27.41
11:18 ET	101	27.39
11:20 ET	300	27.4
11:23 ET	300	27.37
11:25 ET	100	27.37
11:27 ET	2290	27.365
11:30 ET	400	27.35
11:32 ET	1284	27.36
11:34 ET	2573	27.42
11:36 ET	3402	27.4
11:38 ET	9534	27.5
11:39 ET	743	27.46
11:41 ET	300	27.44
11:43 ET	300	27.41
11:52 ET	100	27.41
11:54 ET	100	27.42
11:56 ET	525	27.46
11:59 ET	100	27.48
12:03 ET	200	27.48
12:06 ET	200	27.48
12:08 ET	100	27.51
12:10 ET	1500	27.49
12:12 ET	100	27.495
12:14 ET	200	27.45
12:15 ET	2000	27.38
12:19 ET	100	27.375
12:24 ET	100	27.35
12:26 ET	100	27.26
12:28 ET	300	27.27
12:33 ET	100	27.32
12:35 ET	100	27.345
12:42 ET	100	27.35
12:48 ET	400	27.33
12:50 ET	100	27.3
12:53 ET	300	27.38
12:57 ET	217	27.389
01:00 ET	200	27.385
01:04 ET	100	27.39
01:09 ET	104	27.375
01:11 ET	100	27.395
01:15 ET	200	27.44
01:20 ET	100	27.415
01:22 ET	503	27.38
01:29 ET	235	27.35
01:31 ET	700	27.35
01:33 ET	720	27.36
01:44 ET	331	27.35
01:51 ET	200	27.38
02:02 ET	600	27.3
02:03 ET	100	27.33
02:09 ET	400	27.355
02:12 ET	400	27.32
02:16 ET	213	27.335
02:18 ET	100	27.3
02:20 ET	100	27.28
02:21 ET	128	27.27
02:25 ET	100	27.24
02:27 ET	1854	27.31
02:30 ET	100	27.31
02:32 ET	200	27.35
02:34 ET	414	27.33
02:36 ET	100	27.355
02:38 ET	100	27.33
02:39 ET	100	27.33
02:41 ET	200	27.33
02:43 ET	100	27.33
02:48 ET	536	27.365
02:50 ET	493	27.35
02:52 ET	100	27.35
02:54 ET	400	27.39
02:56 ET	300	27.4
02:57 ET	953	27.3817
02:59 ET	300	27.41
03:01 ET	200	27.41
03:03 ET	600	27.38
03:06 ET	200	27.37
03:08 ET	215	27.39
03:10 ET	100	27.395
03:12 ET	100	27.39
03:14 ET	200	27.38
03:15 ET	129	27.35
03:17 ET	100	27.355
03:19 ET	326	27.35
03:21 ET	300	27.36
03:24 ET	2256	27.355
03:26 ET	100	27.35
03:28 ET	907	27.35
03:30 ET	600	27.365
03:32 ET	900	27.36
03:33 ET	100	27.37
03:35 ET	300	27.4
03:37 ET	400	27.36
03:39 ET	300	27.36
03:42 ET	200	27.36
03:44 ET	231	27.33
03:46 ET	1500	27.39
03:48 ET	100	27.37
03:50 ET	600	27.345
03:51 ET	2026	27.32
03:53 ET	1400	27.285
03:55 ET	3019	27.31
03:57 ET	1100	27.27
04:00 ET	16045	27.31

Data delayed at least 15 minutes.

Nov 5, 2024
- Galapagos to Present Results of Pioneering Innovation in Cancer Cell Therapy at ASH 2024, from 4:01PM ET on Tuesday Nov 05, 2024 by Dow Jones
  4:01PM ET on Tuesday Nov 05, 2024 by Dow Jones
Nov 1, 2024
- DJ Galapagos Is Maintained at Sector Perform by RBC Capital, from 1:17PM ET on Friday Nov 01, 2024 by Dow Jones
  1:17PM ET on Friday Nov 01, 2024 by Dow Jones
Oct 30, 2024
- *DJ Galapagos 9-Mos Rev EUR200.1M >GLPG.BT, from 4:20PM ET on Wednesday Oct 30, 2024 by Dow Jones
  4:20PM ET on Wednesday Oct 30, 2024 by Dow Jones
- Galapagos Reports Third Quarter 2024 Financial Results and Provides Business Update, from 4:01PM ET on Wednesday Oct 30, 2024 by Dow Jones
  4:01PM ET on Wednesday Oct 30, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesGLPG Galapagos NV	1.8B	-28.6x	---
United StatesGMAB Genmab A/S	13.8B	20.7x	+22.71%
United StatesBCRX BioCryst Pharmaceuticals Inc	1.6B	-12.0x	---
United StatesMDXG MiMedx Group Inc	1.4B	18.3x	---
United StatesBEAM Beam Therapeutics Inc	2.1B	-15.5x	---
United StatesTWST Twist Bioscience Corp	2.5B	-12.9x	---
As of 2024-11-26

Galapagos NV is a Belgium-based clinical-stage biotechnology company. The Company is engaged in the discovery and development of small molecule medicines with modes of action. Its pipeline comprises Phase 3, 2, 1, pre-clinical studies and discovery small-molecule and antibody programs in cystic fibrosis, inflammation, and other indications. The Company focuses on developing a portfolio of clinical-stage therapies for the enhancement of existing treatment paradigms. It develops transformational medicines in areas of high unmet need by combining internal with external science with the goal to add years of life and improve of life of patients across the globe. It discovers which proteins that are involved in causing diseases such as, rheumatoid, arthritis, inflammatory bowel disease and fibrosis. The Company acquired CellPoint and AboundBio in order to develop a cell therapy, which is a potential transformative treatment of different types of cancer.

Contact Information

Headquarters: Generaal De Wittelaan L11 A3MALINES (MECHELEN), Belgium 2800
Phone: ---
Fax: ---

Executives

Chairman of the Board, Chief Executive Officer: Paulus Stoffels
Chief Financial Officer, Chief Operating Officer, Executive Vice President, Member of the Management Board: Thad Huston
Chief Human Resource Officer, Executive Vice President, Member of the Management Board: Annelies Missotten
Executive Vice President, General Counsel, Member of the Management Board: Valeria Cnossen
Chief Commercial Officer, Member of the Management Board: Michele Manto

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$1.8B
Revenue (TTM)	$318.7M
Shares Outstanding	65.9M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	0.22
EPS	$-0.95
Book Value	$44.52
P/E Ratio	-28.6x
Price/Sales (TTM)	5.5
Price/Cash Flow (TTM)	---
Operating Margin	-56.63%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Galapagos NV
NASDAQ:GLPGUnited States

Search Criteria

Charts

Recent News

Nov 5, 2024

Galapagos to Present Results of Pioneering Innovation in Cancer Cell Therapy at ASH 2024, from 4:01PM ET on Tuesday Nov 05, 2024 by Dow Jones

Nov 1, 2024

DJ Galapagos Is Maintained at Sector Perform by RBC Capital, from 1:17PM ET on Friday Nov 01, 2024 by Dow Jones

Oct 30, 2024

*DJ Galapagos 9-Mos Rev EUR200.1M >GLPG.BT, from 4:20PM ET on Wednesday Oct 30, 2024 by Dow Jones

Galapagos Reports Third Quarter 2024 Financial Results and Provides Business Update, from 4:01PM ET on Wednesday Oct 30, 2024 by Dow Jones

Biotechnology Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar